Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06626464
PHASE1
A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)
Sponsor: Merck Sharp & Dohme LLC
View on ClinicalTrials.gov
Summary
The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.
Official title: A Phase 1 Clinical Study to Evaluate the Absorption, Metabolism and Excretion of [14C]MK-8189 in Healthy Adults
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2022-05-13
Completion Date
2022-07-08
Last Updated
2026-04-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
[14C]Elpipodect
Oral administration
Locations (1)
Labcorp Clinical Research Unit Inc. (Site 0001)
Madison, Wisconsin, United States